SK284036B6 - Lipozomálna parenterálna kompozícia - Google Patents

Lipozomálna parenterálna kompozícia Download PDF

Info

Publication number
SK284036B6
SK284036B6 SK1222-2000A SK12222000A SK284036B6 SK 284036 B6 SK284036 B6 SK 284036B6 SK 12222000 A SK12222000 A SK 12222000A SK 284036 B6 SK284036 B6 SK 284036B6
Authority
SK
Slovakia
Prior art keywords
cholesterol
liposomal composition
erythropoietin
liposomal
composition
Prior art date
Application number
SK1222-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK12222000A3 (sk
Inventor
Rainer N�ff
Sandro Delmenico
Andr Wetter
Frank-Ulrich Fl�ther
Original Assignee
Cilag Ag International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag International filed Critical Cilag Ag International
Publication of SK12222000A3 publication Critical patent/SK12222000A3/sk
Publication of SK284036B6 publication Critical patent/SK284036B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
SK1222-2000A 1998-02-23 1999-02-12 Lipozomálna parenterálna kompozícia SK284036B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98103111A EP0937456B1 (fr) 1998-02-23 1998-02-23 Dispersion liposomale d'érythropoietine
PCT/IB1999/000249 WO1999042085A1 (fr) 1998-02-23 1999-02-12 Dispersion liposomale d'erythropoietine

Publications (2)

Publication Number Publication Date
SK12222000A3 SK12222000A3 (sk) 2001-11-06
SK284036B6 true SK284036B6 (sk) 2004-08-03

Family

ID=8231466

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1222-2000A SK284036B6 (sk) 1998-02-23 1999-02-12 Lipozomálna parenterálna kompozícia

Country Status (23)

Country Link
US (2) US6645522B2 (fr)
EP (1) EP0937456B1 (fr)
JP (1) JP4613294B2 (fr)
KR (1) KR100591871B1 (fr)
CN (1) CN1184958C (fr)
AT (1) ATE271376T1 (fr)
AU (1) AU750481B2 (fr)
BR (1) BR9908202A (fr)
CA (1) CA2320072C (fr)
CZ (1) CZ296415B6 (fr)
DE (1) DE69825137T2 (fr)
DK (1) DK0937456T3 (fr)
ES (1) ES2224299T3 (fr)
HU (1) HUP0101026A2 (fr)
IL (2) IL137808A0 (fr)
NO (1) NO20004186D0 (fr)
NZ (1) NZ506429A (fr)
PL (1) PL194502B1 (fr)
PT (1) PT937456E (fr)
RU (1) RU2218914C2 (fr)
SI (1) SI0937456T1 (fr)
SK (1) SK284036B6 (fr)
WO (1) WO1999042085A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224299T3 (es) * 1998-02-23 2005-03-01 Cilag Ag International Dispersion liposomal de eritroyetina.
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
EP1111050B1 (fr) * 1999-12-22 2007-03-14 Dade Behring Marburg GmbH Solutions de procalcitonine humaine
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
DE10219545A1 (de) * 2002-04-26 2003-11-06 Lang Florian Regulation der Apoptose
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
JP2004115397A (ja) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd 血管疾患治療薬を含むリポソーム
CA2515160C (fr) * 2003-02-07 2013-01-08 Prometic Biosciences Inc. Acides gras a chaine moyenne, glycerides et analogues utilises en tant que stimulateurs de l'erythropoiese
CN1822844B (zh) * 2003-07-17 2012-05-09 大塚制药株式会社 含配糖物的脂质体
US7645733B2 (en) * 2003-09-29 2010-01-12 The Kenneth S. Warren Institute, Inc. Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
EP1537876A1 (fr) * 2003-12-01 2005-06-08 BioGeneriX AG Formulation d'une solution d'érythropoiétine
DE602005018473D1 (de) * 2004-05-24 2010-02-04 Polymun Scient Immunbio Forsch Superbeladene liposome für die arzneimittelabgabe
KR100684380B1 (ko) 2005-05-24 2007-02-20 한국화학연구원 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법
US9119782B2 (en) * 2006-03-20 2015-09-01 Mary P. McCourt Drug delivery means
WO2008065372A2 (fr) 2006-11-28 2008-06-05 Nautilus Biotech, S.A. Polypeptides d'érythropoïétine modifiés et utilisation de ceux-ci dans des traitements
US20100310636A1 (en) * 2007-05-09 2010-12-09 Gita Sharma Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
JP6189749B2 (ja) * 2010-06-23 2017-08-30 ブライトサイド イノベーションズ，インコーポレイティド レシチン担体小胞とその作製方法
EA018472B1 (ru) * 2010-09-15 2013-08-30 Открытое Акционерное Общество "Протек" Частицы, содержащие эритропоэтин, для лечения и профилактики неврологических и гематологических заболеваний и нарушений
US9693968B2 (en) 2013-03-14 2017-07-04 Jerome J. Schentag Cholestosome vesicles for incorporation of molecules into chylomicrons
CN103751214A (zh) * 2014-01-03 2014-04-30 广州市鼍龙生物技术开发有限公司 一种鳄鱼油纳米脂质体及其制备方法
PL3138556T3 (pl) * 2014-04-30 2022-05-16 Fujifilm Corporation Sposób wytwarzania liposomu
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
JPH087219B2 (ja) 1992-04-27 1996-01-29 雪印乳業株式会社 リポソーム封入生理活性蛋白質の定量方法
JPH06228012A (ja) 1993-01-29 1994-08-16 Dai Ichi Seiyaku Co Ltd リポソーム製剤
CA2120197A1 (fr) * 1993-04-02 1994-10-03 Kenji Endo Dispersions aqueuses stables renfermant des liposomes
US5874075A (en) * 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US6214388B1 (en) * 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells
JP3850468B2 (ja) * 1994-12-28 2006-11-29 中外製薬株式会社 エリスロポエチンのリポソーム製剤
US5858397A (en) * 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
ES2224299T3 (es) * 1998-02-23 2005-03-01 Cilag Ag International Dispersion liposomal de eritroyetina.

Also Published As

Publication number Publication date
NZ506429A (en) 2003-03-28
AU750481B2 (en) 2002-07-18
NO20004186L (no) 2000-08-22
PL342514A1 (en) 2001-06-18
US20020028236A1 (en) 2002-03-07
IL137808A0 (en) 2001-10-31
JP4613294B2 (ja) 2011-01-12
EP0937456B1 (fr) 2004-07-21
JP2002503685A (ja) 2002-02-05
SI0937456T1 (en) 2004-12-31
IL137808A (en) 2007-07-24
US20040052838A1 (en) 2004-03-18
WO1999042085A1 (fr) 1999-08-26
KR20010041152A (ko) 2001-05-15
ES2224299T3 (es) 2005-03-01
CN1298296A (zh) 2001-06-06
EP0937456A1 (fr) 1999-08-25
CZ20002959A3 (cs) 2001-10-17
DE69825137T2 (de) 2005-07-21
CA2320072C (fr) 2009-04-07
DK0937456T3 (da) 2004-11-08
RU2218914C2 (ru) 2003-12-20
HUP0101026A2 (hu) 2001-08-28
DE69825137D1 (de) 2004-08-26
BR9908202A (pt) 2000-10-24
PL194502B1 (pl) 2007-06-29
NO20004186D0 (no) 2000-08-22
CA2320072A1 (fr) 1999-08-26
CZ296415B6 (cs) 2006-03-15
ATE271376T1 (de) 2004-08-15
CN1184958C (zh) 2005-01-19
KR100591871B1 (ko) 2006-06-23
SK12222000A3 (sk) 2001-11-06
US6645522B2 (en) 2003-11-11
PT937456E (pt) 2004-10-29
AU2180899A (en) 1999-09-06

Similar Documents

Publication Publication Date Title
SK284036B6 (sk) Lipozomálna parenterálna kompozícia
RU2526114C2 (ru) Липосомы иринотекана или его солей, способ их получения
DE69531701T2 (de) Sphingosome mit verbesserter arzneistoffabgage
US20100310636A1 (en) Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
US20040126886A1 (en) Liposome for incorporating large amounts of hydrophobic substances
ES2733061T3 (es) Dispersión acuosa de liposomas encapsulantes de oxaliplatino estable y método para estabilización de la misma
IE911231A1 (en) Long-acting liposome peptide pharmaceutical products and¹processes for the preparation thereof
EP1689364A1 (fr) Compositions liposomales stables comprenant une amine lipophile contenant des agents pharmaceutiques
JP3383704B2 (ja) 安定なリポソーム水分散液
US20020058060A1 (en) Liposome for incorporating large amounts of hydrophobic substances
US8992969B2 (en) Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
CN102119924B (zh) 单分散纳米氨曲南脂质体制剂及其制备方法
US10159646B2 (en) Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
MXPA00008213A (en) Erythropoietin liposomal dispersion
CN101732232A (zh) 一种多烯紫杉醇纳米粒组合物
AU2022367142A1 (en) Composition containing antitumor drug, and preparation method therefor and use thereof
CN112773776A (zh) 一种载药纳米粒体系

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20170212